SA
Srinivas Akkaraju (Director) filed 12 Form 4 reports in the trailing twelve months (12 purchases, 1 sale, 2 filed past the two-business-day deadline; 1 filing reported both), most often in Alumis Inc. (ALMS). Across 11 priced purchase filings, the average 21-session return was +35.0% from execution and +27.3% from disclosure (delay-adjusted; derived). The largest single filing was $11.9M of SRRK (287,970 sh across 4 lots, as filed), executed Oct 23. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+35.0%
avg across 11 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+27.3%
same 11 filings, from disclosure
Filings, ttm
12
12 buys · 1 sells · 2 late
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$46.2M
shares × price, as filed
Last traded
Oct 26
Filed Oct 27
Median ADV $31.6M across their filed names
Impact on $10,000 · 12M
$15,239 (+52.4%)
S&P 500 $10,907 (+9.1%) · 43.3 pts ahead
Srinivas Akkaraju
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $92.5M
Sells $1.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
ALMSRecent filings
ALMSPURCHASE
Alumis Inc.
View filing →
$1.3M173,589 sh across 3 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 6:09 PM ET ALMSPURCHASE Alumis Inc. View filing → $905K
125,743 sh × $7.20
Exec Nov 20 2025
Filed Nov 24 2025 · 6:50 PM ET ALMSPURCHASE Alumis Inc. View filing → $1.5M
240,424 sh across 2 lots
Exec Nov 18 2025
Filed Nov 19 2025 · 8:46 PM ET ALMSPURCHASE Alumis Inc. View filing → $1.4M
276,179 sh × $5.25
Exec Nov 13 2025
Filed Nov 17 2025 · 4:59 PM ET SRRKPURCHASE Scholar Rock Holding Corporation View filing → $1.2M
29,599 sh across 3 lots
Exec Oct 7 2025
Filed Dec 16 2025 · 9:07 PM ET † SRRKPURCHASE Scholar Rock Holding Corporation View filing → $18.8M
500,439 sh across 6 lots
Exec Oct 3 2025
Filed Oct 7 2025 · 8:59 PM ET MLYSPURCHASE Mineralys Therapeutics, Inc. View filing → $15.0M
588,235 sh × $25.50
Exec Sep 4 2025
Filed Sep 8 2025 · 8:07 PM ET ALMSPURCHASE Alumis Inc. View filing → $1.5M
320,290 sh across 3 lots
Exec May 2 2025
Filed May 6 2025 · 5:30 PM ET More filings →